Regulatory News In Brief
This article was originally published in The Tan Sheet
FDA issues guidance on splitting tablets
You may also be interested in...
Chaffetz will not challenge Hatch
NDI Guidance Is “Radical Departure” From DSHEA; More Comment Time Needed – Attorney
The new dietary ingredient notification draft guidance is a “radical departure” from current industry practice and FDA should extend the comment period on the draft to one year, an attorney says.
What’s Next? Five Things To Look Out For In April
Generics Bulletin previews the biggest events and changes for industry in the coming month.